相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。Selexipag for the Treatment of Pulmonary Arterial Hypertension
Olivier Sitbon et al.
NEW ENGLAND JOURNAL OF MEDICINE (2015)
Initial Use of Ambrisentan plus Tadalafil in Pulmonary Arterial Hypertension
N. Galie et al.
NEW ENGLAND JOURNAL OF MEDICINE (2015)
Gender and racial differences in nonalcoholic fatty liver disease
Jen-Jung Pan et al.
WORLD JOURNAL OF HEPATOLOGY (2014)
Epidemiology and sociodemographics of systemic lupus erythematosus and lupus nephritis among US adults with Medicaid coverage, 20002004
Candace H. Feldman et al.
ARTHRITIS AND RHEUMATISM (2013)
Race and Association With Disease Manifestations and Mortality in Scleroderma A 20-Year Experience at the Johns Hopkins Scleroderma Center and Review of the Literature
Allan C. Gelber et al.
MEDICINE (2013)
Macitentan and Morbidity and Mortality in Pulmonary Arterial Hypertension
Tomas Pulido et al.
NEW ENGLAND JOURNAL OF MEDICINE (2013)
Riociguat for the Treatment of Pulmonary Arterial Hypertension
Hossein-Ardeschir Ghofrani et al.
NEW ENGLAND JOURNAL OF MEDICINE (2013)
Race and Sex Differences in Response to Endothelin Receptor Antagonists for Pulmonary Arterial Hypertension
Nicole B. Gabler et al.
CHEST (2012)
Pulmonary Arterial Hypertension Baseline Characteristics From the REVEAL Registry
David B. Badesch et al.
CHEST (2010)
Increased mortality in African Americans with idiopathic pulmonary arterial hypertension
Kala K. Davis et al.
JOURNAL OF THE NATIONAL MEDICAL ASSOCIATION (2008)
Now predictors of outcome in idiopathic pulmonary arterial hypertension
SM Kawut et al.
AMERICAN JOURNAL OF CARDIOLOGY (2005)
Mortality from primary pulmonary hypertension in the United States, 1979-1996
DE Lilienfeld et al.
CHEST (2000)